Immunome (IMNM) Stock: Buy, Sell, or Hold?
$18.46
-0.61 (-3.20%)
âŧ
5d:
+3.1%
30d:
+7.33%
90d:
-32.13%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect IMNM Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (70%)
Quality Score
46/100
Position
FAIR
30-Day Fair Range
$17.57 â $19.59
Position: FAIR
Forward P/E & Valuation
-7.6x
Next 12M consensus est.
Wall Street Target
$35.20
+84.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$17.29 / $22.77
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IMNM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IMNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMNM is currently trading at $18.46, which is considered fair relative to its 30-day fair value range of $17.57 to $19.59.
Technical Outlook: Technically, IMNM is in a downtrend. Immediate support is located at $17.29, while resistance sits at $22.77. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.20 (+84.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMNM is in a downtrend. Immediate support is located at $17.29, while resistance sits at $22.77. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.20 (+84.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$17.57 -
$19.59
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Trading Range & Key Levels
30-Day Trading Range
$17.57 -
$19.59
Current vs Trading Range
FAIR
Support Level
$17.29
Resistance Level
$22.77
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding IMNM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 84.6% below Wall St target ($35.20)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-7.56
Wall Street Target
$35.20
(+84.6%)
Revenue Growth (YoY)
-100.0%
Share IMNM Analysis
Share this live IMNM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IMNM)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism about $IMNM, expecting a potential buy move before earnings are announced.
Key Retail Themes:
buy opportunity before earnings
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:29 PM ET
Data refreshes hourly during market hours. Next update: 2:29 PM
Data refreshes hourly during market hours. Next update: 2:29 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 61 BUY |
Advanced IMNM Option Strategies
Professional options setups generated by AI based on today's IMNM price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMNM Research Pages
